Spectrum Pharmaceuticals Inc. (Nasdaq: SPPI) is buying medicine maker Talon Therapeutics Inc.

The purchase price includes $11.3 million in cash and 3 million shares of Spectrum common stock. Talon’s shareholders could also receive up to $195 million in future cash payments based on certain milestones.

Subscribe Now

Complete access to real-time information and analysis of news and trends in the industry.

14-Day Free Trial

No credit card required. Complete access to articles, breaking news and industry data.